SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-013761
Filing Date
2017-11-24
Accepted
2017-11-24 09:09:59
Documents
7
Period of Report
2017-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 56681
2 ex4-1.htm EX-4.1 35456
3 ex4-2.htm EX-4.2 84663
4 ex10-1.htm EX-10.1 170438
5 ex10-2.htm EX-10.2 171489
6 ex10-3.htm EX-10.3 37450
7 ex4-2_001.jpg GRAPHIC 1832
  Complete submission text file 0001493152-17-013761.txt   560460
Mailing Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748
Business Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 171221085
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1